Jump to full article: CenterWatch , 2009-06-01
Intro: Alabama
Diverse Cities : Research Center
MAGRIT is a Phase III clinical study which evaluates the use of a potential new immunotherapy (also called a therapeutic vaccine) in the treatment of Non-Small Cell Lung Cancer (NSCLC).
Various Cities : Research Center New!
Lung Cancer Study CASA404A2302
Alaska
Various Cities : Research Center New!
Lung Cancer Study CASA404A2302
Jump to full article » |